Media coverage about Tivity Health (NASDAQ:TVTY) has been trending positive on Friday, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Tivity Health earned a media sentiment score of 0.46 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.2254523916676 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news headlines that may have impacted Accern Sentiment’s rankings:
- $153.72 Million in Sales Expected for Tivity Health (TVTY) This Quarter (americanbankingnews.com)
- Financial Comparison: Caladrius Biosciences (CLBS) vs. Tivity Health (TVTY) (americanbankingnews.com)
- Zacks: Analysts Expect Tivity Health (TVTY) to Post $0.49 EPS (americanbankingnews.com)
- Tivity Health (TVTY) Scheduled to Post Quarterly Earnings on Tuesday (americanbankingnews.com)
- Tivity director who sparked change at Healthways to leave (nashvillepost.com)
Several research firms have commented on TVTY. BidaskClub downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a research note on Friday, April 13th. Zacks Investment Research raised shares of Tivity Health from a “hold” rating to a “strong-buy” rating and set a $45.00 price target on the stock in a research note on Wednesday, February 28th. Barrington Research lifted their price target on shares of Tivity Health from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Friday, February 23rd. Cantor Fitzgerald reissued an “overweight” rating and set a $53.00 price target on shares of Tivity Health in a research note on Friday, February 23rd. Finally, Chardan Capital reissued a “neutral” rating and set a $41.00 price target (down from $44.00) on shares of Tivity Health in a research note on Friday, February 23rd. Three equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $46.88.
TVTY stock opened at $40.05 on Friday. The company has a market cap of $1,613.81, a price-to-earnings ratio of 23.84, a price-to-earnings-growth ratio of 1.71 and a beta of 0.31. Tivity Health has a one year low of $28.55 and a one year high of $48.50.
Tivity Health (NASDAQ:TVTY) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.32 by $0.09. The firm had revenue of $139.40 million for the quarter, compared to the consensus estimate of $138.22 million. Tivity Health had a net margin of 11.44% and a return on equity of 29.17%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same period last year, the firm posted $0.35 earnings per share. sell-side analysts predict that Tivity Health will post 2.16 EPS for the current fiscal year.
In related news, CEO Donato Tramuto sold 20,000 shares of Tivity Health stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $38.53, for a total value of $770,600.00. Following the transaction, the chief executive officer now directly owns 189,596 shares of the company’s stock, valued at $7,305,133.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 8.42% of the stock is owned by insiders.
WARNING: This story was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://ledgergazette.com/2018/04/20/favorable-media-coverage-somewhat-unlikely-to-impact-tivity-health-tvty-stock-price.html.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.